IDXX
Idexx LaboratoriesPrevious close
513.62
Change
+2.89 / +0.57%
52-Week Range
500.61 – 769.98
P/E (TTM)
35.5
Forward P/E
35.6
Based on consensus earnings for the next 12 months
Market Cap
$40.5B
1M
−5.95%
S&P 500 −2.41% over same period
Volume / Avg Volume
376K / 508K
0.74× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-04 | $1.2B | 4.07 / 4.02 | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-05 | $1.1B | 3.30 / 3.47 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-02 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-11-03 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-04 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-01 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 0 of its 5-year rangeCheap
5-year range 39.1 – 56.9 · Median 47.7
Last 4 quarters: $1.2B in buybacks + $0 in dividends, 2.91% of market cap combined
P/E (TTM)
35.5
P/B
25.1
P/S
8.9
PEG
2.81
Earnings Reaction
Over the last 6 reports, the stock moved ±1.8% on average on the first trading day after, rising 2 times
Most recent −0.56%
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 1 · $1.2MNet selling $1.2M
- 09-04Kingsley Lawrence DDirectorSell$1.2M2,203 shares · Avg price 532.08
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 1.22 | +9.7% | 64.0% | 0.34 | 4.27 |
| FY2026 Q1 | 1.14 | +14.3% | 63.4% | 0.28 | 3.47 |
| FY2025 Q4 | 1.09 | +14.3% | 60.3% | 0.25 | 3.09 |
| FY2025 Q3 | 1.11 | +13.3% | 61.8% | 0.27 | 3.40 |
| FY2025 Q2 | 1.11 | +10.6% | 62.6% | 0.29 | 3.63 |
| FY2025 Q1 | 1.00 | +3.6% | 62.4% | 0.24 | 2.96 |
| FY2024 Q4 | 0.95 | +5.8% | 59.8% | 0.22 | 2.62 |
| FY2024 Q3 | 0.98 | +6.6% | 61.1% | 0.23 | 2.80 |
| FY2024 Q2 | 1.00 | +6.4% | 61.7% | 0.20 | 2.44 |
| FY2024 Q1 | 0.96 | +7.1% | 61.5% | 0.24 | 2.81 |
| FY2023 Q4 | 0.90 | +8.8% | 58.4% | 0.19 | 2.31 |
| FY2023 Q3 | 0.92 | +8.8% | 59.9% | 0.21 | 2.53 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| IDXX | 35.5 | +9.7% | 64.0% | −5.95% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |